The DYRK family of kinases in cancer: molecular functions and therapeutic opportunities J Boni, C Rubio-Perez, N López-Bigas, C Fillat, S de la Luna Cancers 12 (8), 2106, 2020 | 65 | 2020 |
DYRK1A modulates c-MET in pancreatic ductal adenocarcinoma to drive tumour growth J Luna, J Boni, M Cuatrecasas, X Bofill-De Ros, E Núñez-Manchón, ... Gut 68 (8), 1465-1476, 2019 | 58 | 2019 |
Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition F Mateo, EJ Arenas, H Aguilar, J Serra-Musach, GR De Garibay, J Boni, ... Oncogene 36 (19), 2737-2749, 2017 | 41 | 2017 |
Lymphangioleiomyomatosis biomarkers linked to lung metastatic potential and cell stemness G Ruiz de Garibay, C Herranz, A Llorente, J Boni, J Serra-Musach, ... PLoS One 10 (7), e0132546, 2015 | 21 | 2015 |
Study of breast cancer incidence in patients of lymphangioleiomyomatosis O Nuñez, A Román, SR Johnson, Y Inoue, M Hirose, Á Casanova, ... Breast Cancer Research and Treatment 156, 195-201, 2016 | 12 | 2016 |
A decade of RAD51C and RAD51D germline variants in cancer J Boni, A Idani, C Roca, L Feliubadaló, E Tomiak, E Weber, WD Foulkes, ... Human mutation 43 (3), 285-298, 2022 | 10 | 2022 |
Correction: Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness G Ruiz de Garibay, C Herranz, A Llorente, J Boni, J Serra-Musach, ... Plos one 13 (11), e0207586, 2018 | 1 | 2018 |
Systematic proximal mapping of the classical RAD51 paralogs unravel functionally and clinically relevant interactors for genome stability E Simo Cheyou, J Boni, J Boulais, E Pinedo-Carpio, A Malina, ... PLoS Genetics 18 (11), e1010495, 2022 | | 2022 |
RAD51C and RAD51D germline mutations are associated to susceptibility to multiple cancers J Boni, A Idani, E Weber, E Tomiak, W Foulkes, Z el Haffaf, B Rivera EUROPEAN JOURNAL OF HUMAN GENETICS 30 (SUPPL 1), 426-426, 2022 | | 2022 |
A decade of RAD51C/D: Germline pathogenic variants and their phenotypic landscape J Boni, A Idani, C Roca, L Feliubadaló, E Tomiak, E Weber, W Foulkes, ... Authorea Preprints, 2021 | | 2021 |
Dyrk1a in cancer: good or evil? defining properties of dyrk1a kinase as a novel tumor driver J Boni Universitat Pompeu Fabra, 2019 | | 2019 |